{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:45:50Z","timestamp":1747154750845,"version":"3.40.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.amjcard.2017.01.030","type":"journal-article","created":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T12:45:56Z","timestamp":1486730756000},"page":"1401-1406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Use of Antiarrhythmic Medications in Medicare Part D Patients With an Implantable Cardioverter-Defibrillator and Ventricular Tachycardia"],"prefix":"10.1016","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4345-0816","authenticated-orcid":false,"given":"Sean D.","family":"Pokorney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojuan","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley G.","family":"Hammill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy M.","family":"Allen LaPointe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley H.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sana M.","family":"Al-Khatib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2017.01.030_bib1","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2017.01.030_bib2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2017.01.030_bib3","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1056\/NEJM199912163412503","article-title":"A\u00a0randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators","volume":"341","author":"Buxton","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2017.01.030_bib4","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","article-title":"Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators","volume":"335","author":"Moss","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2017.01.030_bib5","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1161\/01.CIR.0000150390.04704.B7","article-title":"Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator","volume":"110","author":"Moss","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2017.01.030_bib6","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa071098","article-title":"Prognostic importance of defibrillator shocks in patients with heart failure","volume":"359","author":"Poole","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2017.01.030_bib7","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1161\/hc0502.103330","article-title":"Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks","volume":"105","author":"Schron","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2017.01.030_bib8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jama.295.2.165","article-title":"Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial","volume":"295","author":"Connolly","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2017.01.030_bib9","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/S0735-1097(00)00615-X","article-title":"Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy: results of a prospective multicenter study. Cooled RF Multi Center Investigators Group","volume":"35","author":"Calkins","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2017.01.030_bib10","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1161\/CIRCULATIONAHA.108.788604","article-title":"Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial","volume":"118","author":"Stevenson","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2017.01.030_bib11","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1161\/CIRCEP.114.001953","article-title":"Early referral for ablation of scar-related ventricular tachycardia is associated with improved acute and long-term outcomes: results from the Heart Center of Leipzig ventricular tachycardia registry","volume":"7","author":"Dinov","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.amjcard.2017.01.030_bib12","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1067\/mhj.2001.117129","article-title":"Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study","volume":"142","author":"Steinberg","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2017.01.030_bib13","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.amjcard.2013.09.023","article-title":"Prevalence, correlates, and temporal trends in antiarrhythmic drug use at discharge after implantable cardioverter defibrillator placement (from the National Cardiovascular Data Registry [NCDR])","volume":"113","author":"Dev","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2017.01.030_bib14","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/0735-1097(89)90310-0","article-title":"Long-term outcome with the automatic implantable cardioverter-defibrillator","volume":"13","author":"Winkle","year":"1989","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2017.01.030_bib15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1161\/01.CIR.71.2.289","article-title":"Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter\/defibrillator","volume":"71","author":"Echt","year":"1985","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2017.01.030_bib16","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1111\/j.1540-8159.1988.tb06349.x","article-title":"Implantable defibrillation: eight years clinical experience","volume":"11","author":"Thomas","year":"1988","journal-title":"Pacing Clin Eectrophysiol"},{"key":"10.1016\/j.amjcard.2017.01.030_bib17","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/0735-1097(88)90292-6","article-title":"The automatic implantable cardioverter-defibrillator: efficacy, complications and survival in patients with malignant ventricular arrhythmias","volume":"11","author":"Kelly","year":"1988","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2017.01.030_bib18","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/0002-8703(94)90076-0","article-title":"Interactions between drugs and devices: experimental and clinical studies","volume":"127","author":"Manz","year":"1994","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2017.01.030_bib19","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.jacc.2015.12.046","article-title":"Use of guideline-directed medications for heart failure before cardioverter-defibrillator implantation","volume":"67","author":"Roth","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2017.01.030_bib20","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1016\/j.amjcard.2011.02.322","article-title":"Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get With the Guidelines-Heart Failure)","volume":"107","author":"Krantz","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2017.01.030_bib21","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.jacc.2004.09.076","article-title":"Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial","volume":"45","author":"McMurray","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2017.01.030_bib22","first-page":"743","article-title":"Out-of-plan medication in Medicare Part D","volume":"20","author":"Roberto","year":"2014","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.amjcard.2017.01.030_bib23","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1056\/NEJM199906173402402","article-title":"Prevention of implantable-defibrillator shocks by treatment with sotalol","volume":"340","author":"Pacifico","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2017.01.030_bib24","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0140-6736(96)09145-3","article-title":"Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT","volume":"349","author":"Julian","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2017.01.030_bib25","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0140-6736(96)08171-8","article-title":"Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT","volume":"349","author":"Cairns","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2017.01.030_bib26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1056\/NEJM199507133330201","article-title":"Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure","volume":"333","author":"Singh","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2017.01.030_bib27","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1161\/CIRCULATIONAHA.107.724880","volume":"116","author":"Scirica","year":"2007","journal-title":"Circulation"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914917301297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914917301297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T07:24:59Z","timestamp":1536045899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914917301297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0002914917301297"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2017.01.030","relation":{},"ISSN":["0002-9149"],"issn-type":[{"type":"print","value":"0002-9149"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Antiarrhythmic Medications in Medicare Part D Patients With an Implantable Cardioverter-Defibrillator and Ventricular Tachycardia","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2017.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}